EWSR1-SMAD3-Positive Fibroblastic Tumor

Area of Science:

• Oncology
• Pathology
• Genetics

Background:

• Recently characterized neoplasm: EWSR1-SMAD3-positive fibroblastic tumor (ESFT).
• Distinct clinicopathologic features and recurrent EWSR1-SMAD3 gene fusion.
• Typically presents as a small, painless tumor in extremity subcutaneous tissues.

Observation:

• Benign behavior with a propensity for local recurrence.
• Comprises two distinct histological components: spindle cells and hyalinized areas with calcifications.
• Immunohistochemically characterized by diffuse nuclear ERG expression; other markers are negative.

Findings:

• Morphological overlap with other soft tissue tumors, including synovial sarcoma and malignant peripheral nerve sheath tumor.
• Consistent ERG nuclear expression aids in identification.
• Distinguishing ESFT from sarcomas is critical.

Implications:

• Correct identification of ESFT is essential to avoid misdiagnosis.
• Prevents unnecessary overtreatment, such as aggressive sarcoma therapy.
• Highlights the importance of molecular diagnostics in soft tissue neoplasia.